[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 5, Issue 3 (Int J Mol Cell Med 2016) ::
Int J Mol Cell Med 2016, 5(3): 125-133 Back to browse issues page
Down Syndrome: Current Status, Challenges and Future Perspectives
Mohammad Kazemi 1, Mansoor Salehi *2, Majid Kheirolahi 3
1- Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran., Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
2- Medical Genetic Center of Genome, Isfahan, Iran., Medical Genetic Center of Genome, Isfahan, Iran. , m_salehi@med.mui.ac.ir
3- Pediatric Inherited Diseases Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran., Pediatric Inherited Diseases Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.
Abstract:   (3168 Views)

Down syndrome (DS) is a birth defect with huge medical and social costs, caused by trisomy of whole or part of chromosome 21. It is the most prevalent genetic disease worldwide and the common genetic cause of intellectual disabilities appearing in about 1 in 400-1500 newborns. Although the syndrome had been described thousands of years before, it was named after John Langdon Down who described its clinical description in 1866. Scientists have identified candidate genes that are involved in the formation of specific DS features. These advances in turn may help to develop targeted therapy for persons with trisomy 21. Screening for DS is an important part of routine prenatal care. Until recently, noninvasive screening for aneuploidy depends on the measurement of maternal serum analytes and ultrasonography. More recent progress has resulted in the development of noninvasive prenatal screening (NIPS) test using cell-free fetal DNA sequences isolated from a maternal blood sample. A review on those achievements is discussed.

Keywords: Down syndrome, trisomy 21, prenatal diagnosis, chromosome abnormality, cell-free fetal DNA (cffDNA), noninvasive prenatal screening (NIPS)
Full-Text [PDF 146 kb]   (2628 Downloads)    
Type of Study: Review | Subject: Genetics & Disease
Received: 2016/05/10 | Accepted: 2016/07/2 | Published: 2016/08/10
Send email to the article author

Add your comments about this article
Your username or Email:

Write the security code in the box >



DOI: 10.22088/acadpub.BUMS.5.3.125


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kazemi M, Salehi M, Kheirolahi M. Down Syndrome: Current Status, Challenges and Future Perspectives. Int J Mol Cell Med. 2016; 5 (3) :125-133
URL: http://ijmcmed.org/article-1-518-en.html
Volume 5, Issue 3 (Int J Mol Cell Med 2016) Back to browse issues page
International Journal of Molecular and Cellular Medicine (IJMCM) International Journal of Molecular and Cellular Medicine (IJMCM)
Persian site map - English site map - Created in 0.052 seconds with 790 queries by yektaweb 3531